Workflow
Paychex Schedules Fourth Quarter Fiscal 2026 Earnings Conference Call on June 24, 2026
Globenewswire· 2026-06-10 21:18
About Paychex Paychex, Inc. (Nasdaq: PAYX) is the digitally driven HR leader that is reimagining how companies address the needs of today's workforce with the most comprehensive, flexible, and innovative HCM solutions for organizations of all sizes. Offering a full spectrum of HR advisory and employee solutions, Paychex pays 1 out of every 11 American private sector workers and is raising the bar in HCM for approximately 800,000 customers in the U.S. and Europe. Every member of the Paychex team is committed ...
SKYX Will Deploy its Technologies During a Renovation of the Iconic 5-Star Hotel “The Mozart Prague” in the Capital of the Czech Republic Owned by Group OTT and Operated by Global Hospitality Leader Accor
Globenewswire· 2026-06-10 21:18
During the course of renovation and new build, SKYX is expected to supply its advanced smart plug & play technologies comprising ceiling lighting, ceiling fans, recessed lights, down lights, EXIT signs, emergency lights, indoor and outdoor lights, wall lights among other advanced smart products. The Renovation is in Process and Will Include Rooms, Suites, Bars, Restaurants, Lobby, Ballroom, Spa, Gym, Meeting Rooms, Corridors, Among Other Hotel Areas The Mozart Prague is Part of Group OTT's European Hospital ...
Aduro Clean Technologies Announces Pricing of US$15.64 Million Underwritten Public Offering and Concurrent Private Placement of up to US$7.17 Million
Globenewswire· 2026-06-10 21:17
LONDON, Ontario, June 10, 2026 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. ("Aduro" or the "Company") (Nasdaq: ADUR) (TSX: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21 century, today announced: for aggregate gross proceeds to the Company of up to US$22,805,214 (collectively, the "Offering"), before deducting discounts, fees and other Offering expenses. Cana ...
Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial
Globenewswire· 2026-06-10 21:15
The shipment of naturally derived psilocybin, comprising both biomass and 5mg capsules, supports a planned Phase 2 clinical trial in the United Kingdom and was completed under export authorization from Health Canada and import authorization from the UK Home Office VANCOUVER, British Columbia, June 10, 2026 (GLOBE NEWSWIRE) -- via IBN – Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN0) (the "Company" or "Optimi"), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, ...
NextNRG’s EzShop, Powered by Gopuff, Goes Live in Florida
Globenewswire· 2026-06-10 21:15
For customers already using EzFill for fuel delivery, EzShop turns the app into a full-service alternative to the traditional gas station run. Customers can now add more than 5,000 convenience, grocery, household, and select automotive products through the EzFill app, with convenience orders fulfilled by Gopuff in as fast as 15 minutes, saving customers a trip to the store. NextNRG plans to continue expanding EzShop into additional markets following the Florida launch, with the service running on Gopuff's e ...
Nexalin Technology Reports Compelling Clinical Trial Results in Brazil to Support Product Launch. Trial Demonstrates 77.8% Anxiety Response Rate and Durable Benefits Across Depression, Insomnia and Quality of Life as Company Advances Brazilian Sales Plan.
Globenewswire· 2026-06-10 21:15
Study using Nexalin's proprietary DIFS™ 15 mA 77.5 Hz treatment platform demonstrated rapid, large- magnitude improvements in anxiety and depression with benefits maintained at 8-week follow-up Results further validate Nexalin's prior clinical data and support the Company's differentiated, non-invasive approach to deep frequency-based neurostimulation No serious adverse events, seizures or manic/hypomanic switches were reported, reinforcing the favorable tolerability profile of Nexalin's technology HOUSTON, ...
SEALSQ’s CEO Carlos Moreira to Lead Quantum Semiconductor Discussions at GSA European Executive Forum in Munich
Globenewswire· 2026-06-10 21:15
Geneva, Switzerland , June 10, 2026 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today announced that its CEO Carlos Moreira, will moderate the high-profile panel "Quantum Semiconductors – Scaling from Lab to Fab" at the Global Semiconductor Alliance ("GSA") European Executive Forum that is being held this week at the Sofitel in Munich, Germany. The GSA ...
MAIA Biotechnology Activates and Opens Enrollment at Second U.S. Clinical Site for International Phase 2 THIO-101 Expansion Trial
Globenewswire· 2026-06-10 21:15
Additional data from MAIA's THIO-101 expansion may further support an accelerated approval filing with the FDA Potential breakthrough therapy holds substantial commercial opportunity in a projected $70 billion global non-small cell lung cancer market by 2030 CHICAGO, June 10, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced that it has activate ...
Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Global Scientific and Clinical Recognition of Platform Technology
Globenewswire· 2026-06-10 21:05
Access the segment here THE WOODLANDS, TX, June 10, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) ("Autonomix" or the "Company"), a medical device company dedicated to advancing precision nerve- targeted treatments, today announced the release of its latest CEO Corner segment featuring President and Chief Executive Officer, Brad Hauser. Some of the statements in this release are "forward-looking statements," which involve risks and uncertainties. Such forward-looking statements can be iden ...
Moody’s Ratings Affirms EPSO-G Baa1 Credit Rating with Stable Outlook
Globenewswire· 2026-06-10 21:05
EPSO-G (legal entity code 302826889, registered address Laisvės pr. 10, Vilnius, Lithuania) The Baa1 investment grade credit reflects the Group's strong financial position, moderate and balanced debt level, and stable and diversified income stream. The announcement of periodic review prepared by Moody's Ratings can be found at https://www.moodys.com. EPSO-G group consists of the holding company EPSO-G and its six direct subsidiaries Amber Grid, Baltpool, Energy cells, EPSO-G Invest, Litgrid and Tetas. EPSO- ...